Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Hepatology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.25674PMID 22378061PMCID PMC3381981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor‐beta signaling promotes hepatocarcinogenesis induced by p53 loss

  2012influential reference
• Myeloid suppressor cells induced by hepatitis C virus suppress T‐cell responses through the production of reactive oxygen species

  2012influential reference
• Dysfunctional B‐cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27‐Positive B‐cell population

  2012cited by this paper
• Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma

  2012cited by this paper
• The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.

  2012cited by this paper
• Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

  2011influential reference
• NF-κB and STAT3 – key players in liver inflammation and cancer

  2011cited by this paper
• NF-κB addiction and its role in cancer: ‘one size does not fit all’

  2011cited by this paper
• Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.

  2011cited by this paper
• Suppression of innate immunity (natural killer cell/interferon‐γ) in the advanced stages of liver fibrosis in mice

  2011cited by this paper
• Chronic liver inflammation and hepatocellular carcinoma: persistence matters.

  2011cited by this paper
• Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function

  2011cited by this paper
• The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

  2011cited by this paper
• B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

  2011cited by this paper
• Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

  2011cited by this paper
• Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas

  2011cited by this paper
• Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis

  2011cited by this paper
• Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells

  2011cited by this paper
• Natural innate and adaptive immunity to cancer.

  2011cited by this paper
• PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients

  2011cited by this paper
• c-Myc induction of programmed cell death may contribute to carcinogenesis

  2011cited by this paper
• Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

  2011cited by this paper
• Faculty Opinions recommendation of An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2010cited by this paper
• Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth

  2010cited by this paper
• CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

  2010cited by this paper
• Antigen-presenting cell function in the tolerogenic liver environment

  2010cited by this paper
• PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice.

  2010cited by this paper
• Natural killer cells in viral hepatitis: facts and controversies

  2010cited by this paper
• A lymphotoxin-driven pathway to hepatocellular carcinoma.

  2009influential reference
• Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.

  2009cited by this paper
• PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.

  2009cited by this paper
• Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β11

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases

  2009cited by this paper
• Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down‐modulation

  2009cited by this paper
• Hepatic fibrosis

  2009cited by this paper
• The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression.

  2009cited by this paper
• Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll‐like receptor 9 activation

  2009cited by this paper
• T cell-derived lymphotoxin regulates liver regeneration.

  2009cited by this paper
• The liver as a lymphoid organ.

  2009cited by this paper
• Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

  2009cited by this paper
• NF-kappaB as a critical link between inflammation and cancer.

  2009cited by this paper
• Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.

  2008cited by this paper
• Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis

  2008cited by this paper
• The function of serotonin within the liver.

  2008cited by this paper
• PD-1 and its ligands in tolerance and immunity.

  2008cited by this paper
• A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

  2008cited by this paper
• Liver: An organ with predominant innate immunity

  2007cited by this paper
• HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL‐12 production

  2007cited by this paper
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

  2007cited by this paper
• Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis

  2007cited by this paper
• Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.

  2007cited by this paper
• Free radicals and antioxidants in normal physiological functions and human disease.

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Interleukin-10 production by effector T cells: Th1 cells show self control

  2007cited by this paper
• Indexing Techniques for CHR based on program transformation

  2007cited by this paper
• The role of cytokines in hepatocellular carcinoma

  2006cited by this paper
• Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

  2006cited by this paper
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans

  2006cited by this paper
• Endotoxin modulates the capacity of CpG‐activated liver myeloid DC to direct Th1‐type responses

  2006influential reference
• The liver as an immunological organ

  2006cited by this paper
• Hepatitis C Virus (HCV) Core Protein-Induced, Monocyte-Mediated Mechanisms of Reduced IFN-α and Plasmacytoid Dendritic Cell Loss in Chronic HCV Infection1

  2006cited by this paper
• De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.

  2005cited by this paper
• The liver as an immunological organ

  2004cited by this paper
• Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.

  2001cited by this paper
• Hepatic Fibrosis

  1955cited by this paper

• Identification of a novel ferroptosis-related gene signature in hepatocellular carcinoma: clinical significance, tumor microenvironment, drug sensitivity, and gene landscape analysis

  2025cites this paper
• Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma

  2025cites this paper
• Microfluidic organ-on-a-chip models for the gut-liver axis: from structural mimicry to functional insights.

  2025cites this paper
• The Associations Between Gallstone Disease and Pan‐Cancer Incidence Risk Based on Over 13 Million Participants

  2025cites this paper
• Pollutants in Microenvironmental Cellular Interactions During Liver Inflammation Cancer Transition and the Application of Multi-Omics Analysis

  2025cites this paper
• Clinical-data-driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma.

  2025cites this paper
• Correlation of Neutrophil-Lymphocyte Ratio, Alpha-Fetoprotein, and PIVKA-II with Staging of HCC Related HBV at Dr. Mohammad Hoesin Hospital, Palembang

  2025cites this paper
• Antioxidant and hepatoprotective activity of Nigella sativa alcoholic extract in a CCl4-induced rat

  2025cites this paper
• Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies.

  2024cites this paper
• Investigating the Effects of AL049796.1 Silencing in Inhibiting High Glucose-Induced Colorectal Cancer Progression

  2024cites this paper
• Non-surgery strategy versus hepatectomy in hepatocellular carcinoma patients with complete response after conversion therapy: a meta-analysis

  2024cites this paper
• Bile acids promote the development of HCC by activating inflammasome

  2023cites this paper
• Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils

  2023cites this paper
• Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study

  2023cites this paper
• 4-octyl itaconate protects against oxidative stress-induced liver injury by activating the Nrf2/Sirt3 pathway through AKT and ERK1/2 phosphorylation.

  2023cites this paper
• The effect of liver disease on hepatic microenvironment and implications for immune therapy

  2023cites this paper
• Molecular basis of Progressive Familial Intrahepatic Cholestasis 3. A proteomics study

  2023cites this paper
• Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin β1 and mediates inflammation

  2023cites this paper
• 3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages

  2022cites this paper
• Advanced radionuclides in diagnosis and therapy for hepatocellular carcinoma

  2022cites this paper
• Extrahepatic factors in hepatic immune regulation

  2022cites this paper
• Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6)

  2022cites this paper
• Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion.

  2022cites this paper
• Examining the gut-liver axis in liver cancer using organoid models.

  2021cites this paper
• The immunological and metabolic landscape in primary and metastatic liver cancer

  2021cites this paper
• Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis

  2021cites this paper
• Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics

  2021cites this paper
• A narrative review of the role of necroptosis in liver disease: a double-edged sword

  2021influential citation
• Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells

  2021cites this paper
• Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice

  2021cites this paper
• Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma

  2020cites this paper
• Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis

  2020cites this paper
• Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.

  2020cites this paper
• Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients

  2020cites this paper
• Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma.

  2020cites this paper
• Peroxisome proliferator‐activated receptor activity correlates with poor survival in patients resected for hepatocellular carcinoma

  2020cites this paper
• Trehalose alleviates oxidative stress-mediated liver injury and Mallor-Denk body formation via activating autophagy in mice

  2020cites this paper
• Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing

  2020cites this paper
• Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma

  2020cites this paper
• Antithrombin attenuates the progression of hepatocellular carcinoma by regulating neutrophil/interleukin‐8 signaling

  2020cites this paper
• An energy restriction‐based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor‐promoting genes

  2019cites this paper
• Liver function and dysfunction – a unique window into the physiological reach of ER stress and the unfolded protein response

  2019cites this paper
• Prognostic role of pretreatment red blood cell distribution width in patients with cancer: A meta-analysis of 49 studies

  2019influential citation
• Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity

  2019cites this paper
• Hepatocellular carcinoma in the setting of alcohol-related liver disease.

  2019cites this paper
• Anti-fibrotic activity of natural products, herbal extracts and nutritional components for prevention of liver fibrosis: review

  2019cites this paper
• Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice.

  2019cites this paper
• HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

  2019cites this paper
• Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.

  2019cites this paper
• Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver

  2018cites this paper
• The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation

  2018cites this paper
• Possible Synergistic Effects of Glutathione and C-Reactive Protein in the Progression of Liver Cirrhosis

  2018cites this paper
• Reaction and Tumorigenesis in Autophagy-deficient Livers

  2018cites this paper
• Detection of a lipid peroxidation-induced DNA adduct across liver disease stages.

  2018cites this paper
• Food components with antifibrotic activity and implications in prevention of liver disease.

  2018cites this paper
• Trehalose activates autophagy and decreases proteasome inhibitor‐induced endoplasmic reticulum stress and oxidative stress‐mediated cytotoxicity in hepatocytes

  2018cites this paper
• ADAM9 mediates the interleukin-6-induced Epithelial-Mesenchymal transition and metastasis through ROS production in hepatoma cells.

  2018cites this paper
• HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers

  2018cites this paper
• Constitutional and functional genetics of human alcohol‐related hepatocellular carcinoma

  2017cites this paper
• Immunotherapy of Hepatocellular Carcinoma

  2017cites this paper
• Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication

  2017cites this paper
• Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells.

  2017cites this paper
• New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?

  2017cites this paper
• Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma

  2017cites this paper
• Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma

  2017cites this paper
• Impact of Cytokines in Hepatocellular Carcinoma Initiation and Progression

  2017cites this paper
• Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma

  2016cites this paper
• Role of the Immune System in Hepatocellular Carcinoma: Implications for Existing and Novel Therapies

  2016cites this paper
• Gene Expression Analysis Indicates Divergent Mechanisms in DEN-Induced Carcinogenesis in Wild Type and Bid-Deficient Livers

  2016cites this paper
• Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response

  2016cites this paper
• Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes

  2016cites this paper
• Biomarkers Associated with Adiposity and Metabolic Dysfunction in Hepatobiliary Tract Cancer

  2016cites this paper
• Forkhead box Q1: A key player in the pathogenesis of tumors (Review).

  2016cites this paper
• Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis

  2016cites this paper
• Perspectives on Treatment for Nonalcoholic Steatohepatitis.

  2016cites this paper
• Obesity and Liver Cancer.

  2016cites this paper
• Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma.

  2016cites this paper
• GRK 2 overexpression inhibits IGF 1-induced proliferation and migration of human hepatocellular carcinoma cells by downregulating EGR 1

  2016cites this paper
• Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma

  2016cites this paper
• Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma

  2016cites this paper
• GRK2 overexpression inhibits IGF1-induced proliferation and migration of human hepatocellular carcinoma cells by downregulating EGR1.

  2016cites this paper
• MCP-1 dependent balance of inflammatory pathways and interplay of immune cells in the liver during injury, fibrosis and injury regression

  2015cites this paper
• Pathogenesis of Hepatocellular Carcinoma Development in Non-alcoholic Fatty Liver Disease

  2015cites this paper
• Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage

  2015cites this paper
• Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition

  2015cites this paper
• Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.

  2015cites this paper
• Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival

  2015cites this paper
• Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers

  2015cites this paper
• Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.

  2015cites this paper
• Mikrobiom zwischen Intestinum und Leber

  2015cites this paper
• Intrahepatic transplantation of adipose-derived stem cells attenuates the progression of non-alcoholic fatty liver disease in rats.

  2015cites this paper
• Update on implications and mechanisms of angiogenesis in liver fibrosis

  2015cites this paper
• Growth arrest and DNA damage‐inducible 34 regulates liver regeneration in hepatic steatosis in mice

  2015cites this paper
• Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

  2015cites this paper
• Extracellular Nucleic Acids and Cancer

  2015cites this paper
• Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis

  2015cites this paper
• Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure.

  2014cites this paper
• Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.

  2014cites this paper
• β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.

  2014cites this paper
• Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression

  2014influential citation